Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Identifying effective and/or safe doses by stepwise confidence intervals for ratios.

Frank Bretz1, Ludwig A Hothorn, Jason C Hsu

  • 1Bioinformatics Unit, University of Hannover, Herrenhäuser Str. 2, D-30419 Hannover, Germany. bretz@bioinf.uni-hannover.de

Statistics in Medicine
|March 11, 2003
PubMed
Summary

This study introduces new stepwise confidence intervals for estimating optimal drug doses in clinical trials. These intervals efficiently identify effective and safe doses without complex adjustments, aiding study design.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of paraspinal muscle fatty infiltration in predicting adjacent segment disease after lumbar spinal fusion: a systematic review and meta-analysis.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026
Same author

Interpretable Machine Learning Framework for Predicting Major Adverse Cardiovascular Events in Rheumatoid Arthritis Using Electronic Health Records: Multicenter Cohort Study.

JMIR formative research·2026
Same author

The CRT-Estimands Framework for Cluster Randomized Trials.

JAMA·2026
Same author

Plant Kelch phosphatases are Ser/Thr phosphatases involved in cell cycle regulation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

CRT-Estimands Framework: consensus based extension of the ICH E9(R1) addendum for cluster randomised trials.

BMJ (Clinical research ed.)·2026
Same author

Impact of semaglutide pretreatment on reproductive outcomes in women with overweight and obesity with infertility: a real-world multicenter cohort study.

Reproductive biology and endocrinology : RB&E·2026

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmacometrics

Background:

  • Randomized clinical trials often compare multiple drug doses against a placebo.
  • Identifying minimum effective dose (MED) and maximum safe dose (MSD) is crucial for drug development.
  • Existing methods like step-down procedures for standardized differences have limitations.

Purpose of the Study:

  • To propose novel stepwise confidence intervals for the ratio of population means in dose-finding studies.
  • To provide a method for simultaneously estimating MED and MSD.
  • To investigate power concepts and enable sample size determination for accurate dose estimation.

Main Methods:

  • Utilizing the ratio of population means as the primary metric.
  • Developing stepwise confidence intervals that do not require multiplicity adjustments.

Related Experiment Videos

  • Comparing the performance of the proposed intervals with existing test procedures.
  • Investigating power concepts relevant to dose estimation.

    • Main Results:

    • The proposed stepwise confidence intervals yield decisions consistent with associated test procedures.
    • The method simplifies multiplicity adjustments in dose-finding analyses.
    • The framework facilitates sample size determination for achieving desired precision in dose estimation.
    • Numerical studies demonstrate the applicability of the proposed methods.

    Conclusions:

    • Stepwise confidence intervals offer an efficient approach for estimating relevant doses in clinical trials.
    • This methodology enhances the design phase by enabling precise sample size calculations.
    • The proposed method provides a valuable tool for optimizing drug development and clinical trial design.